There are 1105 resources available
Which endpoints? Clinical endpoints and surrogacies
Presenter: Nadia Harbeck
Session: Session in collaboration with AACR - Walkthroughs in clinical trials in the era of molecular oncology
Resources:
Slides
Webcast
Invited Discussant 626MO and 627MO
Presenter: Yang Xia
Session: Mini Oral session: Thoracic malignancies
Resources:
Slides
Webcast
464MO - Comprehensive geriatric assessment, patterns of care, and outcome of palliative chemotherapy in elderly patients with advanced solid tumors: A prospective observational study from India
Presenter: Mridul Khanna
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Advancing ADCs: Managing toxicities and harnessing combination treatments
Presenter: Emiliano Calvo
Session: Latest advances/controversies in drug development
Resources:
Slides
Webcast
Other emerging targeted agents in different GI cancers: Are they ready for primetime?
Presenter: Kohei Shitara
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Challenges of equitable drug access: The WHO Essential Diagnostics List (EDL) for all or high-end molecules for few?
Presenter: Dario Trapani
Session: Cancer in low- or middle-income countries (LMICs): Challenges to prevention and providing equitable care
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Thoracic malignancies
Resources:
Webcast
Invited Discussant 526MO, 463MO and 464MO
Presenter: Stein Kaasa
Session: Mini oral session: Supportive and palliative care
Resources:
Slides
Webcast
Rare targets and comprehensive genome profiling
Presenter: Angela Lamarca
Session: Personalising gastrointestinal (GI) oncology: From old to new target inhibition
Resources:
Slides
Webcast
Artificial intelligence (AI): Shaping the future of drug development
Presenter: Udai Banerji
Session: Latest advances/controversies in drug development
Resources:
Slides
Webcast